scorecardresearch
Tuesday, July 22, 2025
TopicPfizer

Topic: Pfizer

Why the above-90% effective Moderna and Pfizer vaccines are truly a breakthrough

The most important challenge for development of an mRNA vaccine remains its inherent instability.

Pfizer Covid vaccine faces hurdles after USFDA filing

Shown to be 95% effective and without any major safety issues, their vaccine could be the first to be cleared for use, but first it must undergo a thorough vetting.

There’s light at the end of the Covid tunnel — the glimmer of a vaccine needle

With Pfizer, Moderna as well as developers of Sputnik V and CoronaVac citing over 90% efficacy of their vaccines, the world finally has a reason to hope 2021 will be different.

Tracking side effects will be the next big challenge for Pfizer, Moderna Covid vaccines

The side-effect reports of the vaccine have the potential to be a gold mine for anti-vaxxers as vaccine skepticism grows around the world.

Pfizer Covid vaccine reaches key safety milestone, to seek emergency US FDA approval

Pfizer CEO Albert Bourla says important questions about the vaccine still remain to be answered, including how durable the protection could be.

Moderna’s Covid vaccine offers antidote to Pfizer’s deep-freeze problem

While Pfizer's vaccine has to be kept in -70 degree and can only last up to 5 days, Moderna's vaccine can last up to 30 days in regular freezers.

Modi govt eyes pvt sector vaccinators for Covid as India has only 70,000 in public sector

These vaccinators run Universal Immunisation Programme that inoculates mothers & children, and govt is concerned about diverting resources for Covid vaccine.

India’s mRNA-based Covid vaccine won’t need ultra cold conditions for storage — Pune firm

Gennova Biopharmaceuticals CEO Sanjay Singh tells ThePrint their vaccine could be stored at around 2 to 8 degrees Celsius, and the trial is likely to be completed by March.

Pfizer vaccine success opens hot stock-market trade

Given the bets the market has seen in the different pandemic phases — from ventilator makers to medical gloves suppliers — it’s no surprise this new phase is attracting attention.

Temperature challenge can make Pfizer Covid vaccine a shot for the rich

The investment and coordination required to build deep-freeze production, storage & transportation networks for the vaccine will ensure that only rich nations are guaranteed access.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.